DFA US Small Cap Growth Instl holds a quantitatively derived Gold Morningstar Medalist Rating. The rating reflects that it has scored particularly well on factors Morningstar research associates with future outperformance relative to category peers.
DFA U.S. Small Cap Growth Portfolio Institutional Class DSCGX
- NAV / 1-Day Return 32.44 / +0.84 %
- Total Assets 1.9B
-
Adj. Expense Ratio
0.310%
- Expense Ratio 0.310%
- Distribution Fee Level Low
- Share Class Type Institutional
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.59%
- Turnover 18%
USD | NAV as of Oct 02, 2026 | 1-Day Return as of Oct 02, 2026, 12:11 AM GMT+0
Morningstar’s Analysis DSCGX
Will DSCGX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 6.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Halozyme Therapeutics Inc | 0.76 | 15M | Healthcare |
Medpace Holdings Inc | 0.76 | 15M | Healthcare |
Crown Holdings Inc | 0.71 | 14M | Consumer Cyclical |
Five Below Inc | 0.67 | 13M | Consumer Cyclical |
Manhattan Associates Inc | 0.66 | 13M | Technology |
Exelixis Inc | 0.65 | 13M | Healthcare |
Sterling Infrastructure Inc | 0.62 | 12M | Industrials |
Texas Roadhouse Inc | 0.61 | 12M | Consumer Cyclical |
Allegion PLC | 0.61 | 12M | Industrials |
IES Holdings Inc | 0.61 | 12M | Industrials |